Acciones Lexagene Holdings Inc Toronto S.E.
Acciones
WEY
CA52886L1031
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-44,08 % | 7633,99 M | |
+8,98 % | 3607,44 M | |
+3,94 % | 2364,59 M | |
-24,94 % | 1861,62 M | |
-17,38 % | 1737,66 M | |
+4,89 % | 913 M | |
+21,75 % | 763 M | |
-11,57 % | 678 M | |
-30,82 % | 500 M |